This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Importin
From Proteopedia
(Difference between revisions)
| Line 35: | Line 35: | ||
**[[1ee5]] – yIPO NLS-binding domain (mutant) + nucleoplasmin<br /> | **[[1ee5]] – yIPO NLS-binding domain (mutant) + nucleoplasmin<br /> | ||
**[[1un0]], [[2c1t]] – yIPO NLS-binding domain (mutant) + Nup2<br /> | **[[1un0]], [[2c1t]] – yIPO NLS-binding domain (mutant) + Nup2<br /> | ||
| + | **[[5h2x]], [[5h2w]] – yIPO NLS-binding domain + ubiquitin-like specific protease<br /> | ||
| + | **[[4xzr]] – yIPO NLS-binding domain + HEH1<br /> | ||
| + | **[[4pvz]] – yIPO NLS-binding domain + HEH2<br /> | ||
| + | **[[4rxh]] – IPO NLS-binding domain + SV40 large T antigen – ''Neurospora crassa''<br /> | ||
*''IPO-α complex with protein'' | *''IPO-α complex with protein'' | ||
| Line 49: | Line 53: | ||
**[[4mz5]], [[4mz6]] – mIPO NLS-binding domain + dUTPase<br /> | **[[4mz5]], [[4mz6]] – mIPO NLS-binding domain + dUTPase<br /> | ||
**[[4oih]] – mIPO NLS-binding domain + guanine nucleotide exchange factor SRM1<br /> | **[[4oih]] – mIPO NLS-binding domain + guanine nucleotide exchange factor SRM1<br /> | ||
| + | **[[5svz]] – mIPO NLS-binding domain + TAT NLS motif<br /> | ||
| + | **[[5wum]], [[5wun]], [[5x8n]] – mIPO NLS-binding domain + Epstein Barr antigen<br /> | ||
| + | **[[5huw]] – mIPO NLS-binding domain + HSVI large terminase<br /> | ||
| + | **[[5huy]] – mIPO NLS-binding domain + HSMV small terminase<br /> | ||
| + | **[[5hhg, [[5fc8]] – mIPO NLS-binding domain + dengue 2 NS5<br /> | ||
| + | **[[5ekg]], [[5ekf]], [[5e6q]] – mIPO NLS-binding domain + XPG2<br /> | ||
| + | **[[5d5k]] – mIPO NLS-binding domain + PARP 2<br /> | ||
| + | **[[5ctt]] – mIPO NLS-binding domain + SART3/TIP110<br /> | ||
| + | **[[5b56]] – mIPO NLS-binding domain + HIV-1 VPR<br /> | ||
| + | **[[4zdu]] – mIPO NLS-binding domain + influenza nucleoprotein<br /> | ||
| + | **[[4yi0]] – mIPO NLS-binding domain + Nup121<br /> | ||
| + | **[[5klr]], [[5klt]] – mIPO NLS-binding domain + NLS <br /> | ||
| + | **[[5k9s]] – mIPO NLS-binding domain + HNF-b <br /> | ||
**[[4b18]] – hIPO NLS-binding domain + telomerase reverse transcriptase<br /> | **[[4b18]] – hIPO NLS-binding domain + telomerase reverse transcriptase<br /> | ||
**[[4wv6]] – hIPO NLS-binding domain + TFIID<br /> | **[[4wv6]] – hIPO NLS-binding domain + TFIID<br /> | ||
| Line 108: | Line 125: | ||
**[[4uad]] – hIPO NLS-binding domain + influenza RNA polymerase<br /> | **[[4uad]] – hIPO NLS-binding domain + influenza RNA polymerase<br /> | ||
| + | |||
| + | *IPO-β | ||
| + | |||
| + | **[[4xrk]] – IPO – ''Chaetomium thermophilum'' <br /> | ||
*IPO-β 1 (karyopherin β 1) | *IPO-β 1 (karyopherin β 1) | ||
| Line 137: | Line 158: | ||
**[[4fdd]], [[4jlq]], [[4oo6]] – hIPO + RNA binding protein peptide<br /> | **[[4fdd]], [[4jlq]], [[4oo6]] – hIPO + RNA binding protein peptide<br /> | ||
**[[4fq3]] – hIPO + FUS peptide<br /> | **[[4fq3]] – hIPO + FUS peptide<br /> | ||
| + | **[[5tqc]] – hIPO + RPL4 peptide<br /> | ||
| + | **[[5j3v]] – hIPO + histone H3 peptide<br /> | ||
*IPO-β 3 (Karyopherin β 3) | *IPO-β 3 (Karyopherin β 3) | ||
| Line 146: | Line 169: | ||
**[[3w3y]] – yIPO + Nup53P<br /> | **[[3w3y]] – yIPO + Nup53P<br /> | ||
**[[3w3z]] – yIPO + RANGTP<br /> | **[[3w3z]] – yIPO + RANGTP<br /> | ||
| + | **[[5h2v]] – yIPO + ubiquitin-like specific protease<br /> | ||
| + | **[[4zj7]] – yIPO + CDC14<br /> | ||
*IPO-12 (Transportin-3) | *IPO-12 (Transportin-3) | ||
Revision as of 09:42, 15 June 2017
| |||||||||||
3D structures of importin
Updated on 15-June-2017 {{#tree:id=OrganizedByTopic|openlevels=0|
- IPO-α
- IPO-α complex with NLS peptide
- 1ejl – mIPO NLS-binding domain + SV40 large T antigen
- 1ejy – mIPO NLS-binding domain + nucleoplasmin
- 2ynr – mIPO NLS-binding domain + B54NLS
- 2yns – rIPO NLS-binding domain + B54NLS - rice
- 1bk6 – yIPO NLS-binding domain + SV40 large T antigen
- 1ee4 – yIPO NLS-binding domain (mutant) + c-Myc
- 1ee5 – yIPO NLS-binding domain (mutant) + nucleoplasmin
- 1un0, 2c1t – yIPO NLS-binding domain (mutant) + Nup2
- 5h2x, 5h2w – yIPO NLS-binding domain + ubiquitin-like specific protease
- 4xzr – yIPO NLS-binding domain + HEH1
- 4pvz – yIPO NLS-binding domain + HEH2
- 4rxh – IPO NLS-binding domain + SV40 large T antigen – Neurospora crassa
- 1ejl – mIPO NLS-binding domain + SV40 large T antigen
- IPO-α complex with protein
- 1wa5 – yIPO NLS-binding domain + GTPase Ran + IPO-α re-exporter
- 1wa5 – yIPO NLS-binding domain + GTPase Ran + IPO-α re-exporter
- IPO-α 1
- IPO-α 1 complex with NLS peptide
- 4mz5, 4mz6 – mIPO NLS-binding domain + dUTPase
- 4oih – mIPO NLS-binding domain + guanine nucleotide exchange factor SRM1
- 5svz – mIPO NLS-binding domain + TAT NLS motif
- 5wum, 5wun, 5x8n – mIPO NLS-binding domain + Epstein Barr antigen
- 5huw – mIPO NLS-binding domain + HSVI large terminase
- 5huy – mIPO NLS-binding domain + HSMV small terminase
- [[5hhg, 5fc8 – mIPO NLS-binding domain + dengue 2 NS5
- 5ekg, 5ekf, 5e6q – mIPO NLS-binding domain + XPG2
- 5d5k – mIPO NLS-binding domain + PARP 2
- 5ctt – mIPO NLS-binding domain + SART3/TIP110
- 5b56 – mIPO NLS-binding domain + HIV-1 VPR
- 4zdu – mIPO NLS-binding domain + influenza nucleoprotein
- 4yi0 – mIPO NLS-binding domain + Nup121
- 5klr, 5klt – mIPO NLS-binding domain + NLS
- 5k9s – mIPO NLS-binding domain + HNF-b
- 4b18 – hIPO NLS-binding domain + telomerase reverse transcriptase
- 4wv6 – hIPO NLS-binding domain + TFIID
- 4b8o – rIPO NLS-binding domain + SV40
- 4b8p – rIPO NLS-binding domain + A89
- 4bpl – rIPO NLS-binding domain + nucleoplasmin
- 4bqk – rIPO NLS-binding domain + VirD2
- 4mz5, 4mz6 – mIPO NLS-binding domain + dUTPase
- IPO-α 1 complex with protein
- IPO-α 2
- IPO-α 2 complex with NLS peptide
- 1pjm – mIPO NLS-binding domain + retinoblastoma-associated protein
- 1pjn – mIPO NLS-binding domain + histone-binding protein N1/N2
- 1q1s, 1q1t – mIPO NLS-binding domain + SV40 large T antigen
- 1y2a, 3q5u – mIPO NLS-binding domain + phospholipid scramblase
- 2c1m – mIPO NLS-binding domain + Nup50
- 3btr – mIPO NLS-binding domain + androgen receptor
- 3knd – mIPO NLS-binding domain + targeting protein for KXLP2
- 3l3q – mIPO NLS-binding domain + library peptide
- 3oqs – mIPO NLS-binding domain + CLIC4
- 3rz9 – mIPO NLS-binding domain + KU80
- 3rzx – mIPO NLS-binding domain + KU70
- 3tpm – mIPO NLS-binding domain + MAL
- 3ve6 – mIPO NLS-binding domain + Venezuelan equine encephalitis virus
- 3uvu – mIPO NLS-binding domain + flap endonuclease
- 3ukw, 3ukx – mIPO NLS-binding domain + BIMAX
- 3uky, 3ukz, 3ul0 – mIPO NLS-binding domain + nuclear CAP-binding protein
- 3ul1 – mIPO NLS-binding domain + nucleoplasmin
- 4htv – mIPO NLS-binding domain + capsid protein
- 4ba3 – mIPO NLS-binding domain + A89NLS
- 3zio, 3zip, 3ziq, 3zir – mIPO NLS-binding domain + minor site-specific NLS
- 3zin – mIPO NLS-binding domain + nucleolar RNA helicase
- 1pjm – mIPO NLS-binding domain + retinoblastoma-associated protein
- IPO-α 2 complex with protein
- IPO-α 3
- 4uae – hIPO NLS-binding domain + influenza RNA polymerase
- 4uae – hIPO NLS-binding domain + influenza RNA polymerase
- IPO-α 6
- 4u2x – hIPO C terminal + ebola VP24
- 4u2x – hIPO C terminal + ebola VP24
- IPO-α 7
- 4uad – hIPO NLS-binding domain + influenza RNA polymerase
- 4uad – hIPO NLS-binding domain + influenza RNA polymerase
- IPO-β
- 4xrk – IPO – Chaetomium thermophilum
- 4xrk – IPO – Chaetomium thermophilum
- IPO-β 1 (karyopherin β 1)
- IPO-β 1 complex with protein
- 1qgx, 1qgr – hIPO + IPO-α 2 IBB domain
- 1ibr – hIPO + GTPase Ran
- 2bku, 3ea5 – yIPO + GTPase Ran
- 1f59, 1o6p, 1o6o – hIPO + FXFG nucleoporin repeats
- 1m5n – hIPO HEAT repeats 1-11 + parathyroid hormone-related protein NLS peptide
- 2p8q, 2q5d, 2qna, 3lww – hIPO + RNA U transporter N terminal
- 1qgr, 3w5k – hIPO + zinc finger protein SNAI1
- 2bpt – yIPO + Nup1
- 1ukl – mIPO + SREBP-2
- 1qgx, 1qgr – hIPO + IPO-α 2 IBB domain
- IPO-β 2 (Transportin 1)
- IPO-β 2 complex with protein
- IPO-β 3 (Karyopherin β 3)
- IPO-12 (Transportin-3)
- IPO-13 (karyopherin 13)
}}
References
- ↑ Mattaj IW, Englmeier L. Nucleocytoplasmic transport: the soluble phase. Annu Rev Biochem. 1998;67:265-306. PMID:9759490 doi:http://dx.doi.org/10.1146/annurev.biochem.67.1.265
- ↑ Pumroy RA, Cingolani G. Diversification of importin-alpha isoforms in cellular trafficking and disease states. Biochem J. 2015 Feb 15;466(1):13-28. doi: 10.1042/BJ20141186. PMID:25656054 doi:http://dx.doi.org/10.1042/BJ20141186

